PMV Pharmaceuticals, Inc.PMVPNASDAQ
LOADING
|||
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
1.56%
↑ 131% above average
Average (26q)
-5.10%
Historical baseline
Range
High:14.32%
Low:-22.36%
Volatility
-718.8%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 1.56% |
| Q2 2025 | -6.10% |
| Q1 2025 | 14.32% |
| Q4 2024 | -14.99% |
| Q3 2024 | -8.52% |
| Q2 2024 | -10.70% |
| Q1 2024 | 3.60% |
| Q4 2023 | 3.70% |
| Q3 2023 | 2.46% |
| Q2 2023 | 6.32% |
| Q1 2023 | -1.50% |
| Q4 2022 | -9.22% |
| Q3 2022 | -8.33% |
| Q2 2022 | 3.94% |
| Q1 2022 | -0.80% |
| Q4 2021 | -22.36% |
| Q3 2021 | -15.69% |
| Q2 2021 | -11.79% |
| Q1 2021 | -11.17% |
| Q4 2020 | -20.69% |
| Q3 2020 | -7.62% |
| Q2 2020 | -5.63% |
| Q1 2020 | -4.07% |
| Q4 2019 | -14.21% |
| Q3 2019 | -0.30% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |